HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: An analysis from the JUPITER trial Academic Article Article uri icon

Overview

MeSH Major

  • Lipoproteins, HDL

abstract

  • AstraZeneca.

publication date

  • July 23, 2010

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(10)60713-1

PubMed ID

  • 20655105

Additional Document Info

start page

  • 333

end page

  • 9

volume

  • 376

number

  • 9738